The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
MAINZ, Germany & MENLO PARK, Calif.--(BUSINESS WIRE)--Credence MedSystems and SCHOTT AG have formed a collaboration for the application of Credence Companion® technology with SCHOTT’s pre-fillable ...
An auto-disable syringe is used to vaccinate a child in Kenya. Photo by UNICEF/Siegfried Modola. A nurse injects a patient with a syringe of antibiotics, reloads and moves on to the next patient in ...
LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback